The Hydration Pharmaceuticals Co (ASX:HPC) Enterprise Value: A$6.41 Mil (As of Jun. 26, 2026) ***


What is The Hydration Pharmaceuticals Co Enterprise Value?

The Hydration Pharmaceuticals Co ASX:HPC -20.00% Enterprise Value is A$6.41 Mil as of Jun. 26, 2026. The stock has 3 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, The Hydration Pharmaceuticals Co's Enterprise Value is A$6.41 Mil. The Hydration Pharmaceuticals Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-4.17 Mil. Therefore, The Hydration Pharmaceuticals Co's EV-to-EBIT ratio for today is -1.54.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, The Hydration Pharmaceuticals Co's Enterprise Value is A$6.41 Mil. The Hydration Pharmaceuticals Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-4.17 Mil. Therefore, The Hydration Pharmaceuticals Co's EV-to-EBITDA ratio for today is -1.54.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, The Hydration Pharmaceuticals Co's Enterprise Value is A$6.41 Mil. The Hydration Pharmaceuticals Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$3.75 Mil. Therefore, The Hydration Pharmaceuticals Co's EV-to-Revenue ratio for today is 1.71.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, The Hydration Pharmaceuticals Co's Enterprise Value is A$6.41 Mil. The Hydration Pharmaceuticals Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$-5.53 Mil. Therefore, The Hydration Pharmaceuticals Co's EV-to-OCF ratio for today is -1.16.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, The Hydration Pharmaceuticals Co's Enterprise Value is A$6.41 Mil. The Hydration Pharmaceuticals Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-5.53 Mil. Therefore, The Hydration Pharmaceuticals Co's EV-to-FCF ratio for today is -1.16.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.

The Hydration Pharmaceuticals Co  (ASX:HPC) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

The Hydration Pharmaceuticals Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6.409/-4.174
=-1.54

The Hydration Pharmaceuticals Co's current Enterprise Value is A$6.41 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-4.17 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

The Hydration Pharmaceuticals Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=6.409/-4.174
=-1.54

The Hydration Pharmaceuticals Co's current Enterprise Value is A$6.41 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-4.17 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

The Hydration Pharmaceuticals Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6.409/3.751
=1.71

The Hydration Pharmaceuticals Co's current Enterprise Value is A$6.41 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$3.75 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

The Hydration Pharmaceuticals Co's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=6.409/-5.533
=-1.16

The Hydration Pharmaceuticals Co's current Enterprise Value is A$6.41 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$-5.53 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

The Hydration Pharmaceuticals Co's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6.409/-5.533
=-1.16

The Hydration Pharmaceuticals Co's current Enterprise Value is A$6.41 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-5.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co Enterprise Value Related Terms

The Hydration Pharmaceuticals Co Enterprise Value Historical Data

* Premium members only.

The historical data trend for The Hydration Pharmaceuticals Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co Enterprise Value Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
24.73 13.29 9.43 0.41 0.47

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Enterprise Value Get a 7-Day Free Trial Premium Member Only 9.43 6.62 0.41 2.13 0.47

ASX:HPC vs SYY, USFD, PFGC: Enterprise Value Comparison

For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Hydration Pharmaceuticals Co Enterprise Value vs Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where The Hydration Pharmaceuticals Co's Enterprise Value falls into.


The Hydration Pharmaceuticals Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

The Hydration Pharmaceuticals Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Enterprise Value (A: Dec. 2025 )
=Market Cap+Preferred Stock+Long-Term Debt & Capital Lease Obligation
=2.154005+0+0
+Short-Term Debt & Capital Lease Obligation+Minority Interest-Cash, Cash Equivalents, Marketable Securities
+0+0-1.684
=0.47

The Hydration Pharmaceuticals Co's Enterprise Value for the quarter that ended in Dec. 2025 is calculated as

Enterprise Value (Q: Dec. 2025 )
=Market Cap+Preferred Stock+Long-Term Debt & Capital Lease Obligation
=2.154005+0+0
+Short-Term Debt & Capital Lease Obligation+Minority Interest-Cash, Cash Equivalents, Marketable Securities
+0+0-1.684
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of A$6.41 Mil mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a Enterprise Value of A$6.41 Mil as of Jun. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on The Hydration Pharmaceuticals Co and its competitors.
Is The Hydration Pharmaceuticals Co's Enterprise Value too high?
The Hydration Pharmaceuticals Co's current Enterprise Value is A$6.41 Mil.
How does The Hydration Pharmaceuticals Co's Enterprise Value compare to SYY and USFD?
The Hydration Pharmaceuticals Co's Enterprise Value of A$6.41 Mil can be compared against companies in the Retail - Defensive industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Retail - Defensive company?
A good Enterprise Value depends on the Retail - Defensive industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on The Hydration Pharmaceuticals Co and its competitors. The Hydration Pharmaceuticals Co's current Enterprise Value is A$6.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Enterprise Value of A$6.41 Mil. The current Enterprise Value is A$6.41 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Enterprise Value is A$6.41 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Hydration Pharmaceuticals Co Business Description

Address 6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.